GLENMEDE TRUST CO NA - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2020$27,000
+12.5%
2,099
-1.1%
0.00%
Q2 2020$24,000
-79.3%
2,123
-50.4%
0.00%
-100.0%
Q1 2020$116,0000.0%4,2770.0%0.00%0.0%
Q4 2019$116,000
-33.7%
4,277
-30.6%
0.00%0.0%
Q3 2019$175,000
+4.8%
6,159
+1.8%
0.00%0.0%
Q2 2019$167,000
-16.5%
6,0500.0%0.00%0.0%
Q1 2019$200,000
+0.5%
6,050
-12.1%
0.00%0.0%
Q4 2018$199,000
+128.7%
6,879
+193.3%
0.00%
Q2 2018$87,000
+7.4%
2,345
-2.1%
0.00%
Q1 2018$81,0000.0%2,3960.0%0.00%
Q4 2017$81,000
+5.2%
2,396
+11.3%
0.00%
Q3 2017$77,000
+92.5%
2,1530.0%0.00%
Q2 2017$40,0000.0%2,1530.0%0.00%
Q1 2017$40,000
+122.2%
2,153
+86.7%
0.00%
Q4 2016$18,000
-30.8%
1,153
-11.5%
0.00%
Q3 2016$26,000
-93.6%
1,303
-90.3%
0.00%
-100.0%
Q2 2016$409,000
+718.0%
13,404
+892.9%
0.00%
Q1 2016$50,000
-10.7%
1,350
+2.7%
0.00%
Q4 2015$56,000
+16.7%
1,315
+2.5%
0.00%
Q3 2015$48,000
+11.6%
1,283
+0.3%
0.00%
Q2 2015$43,000
-99.7%
1,279
-99.7%
0.00%
-100.0%
Q1 2015$16,418,000
+4.9%
463,816
+0.9%
0.12%
-2.4%
Q4 2014$15,650,000
-6.3%
459,550
+6.1%
0.12%
-15.8%
Q3 2014$16,705,000
+4.6%
433,184
+5.5%
0.15%
+1.4%
Q2 2014$15,975,000
+24.9%
410,523
+9.7%
0.14%
+21.0%
Q1 2014$12,790,000
+90.8%
374,161
+17.0%
0.12%
+75.0%
Q4 2013$6,705,000
-24.8%
319,683
-17.0%
0.07%
-35.8%
Q3 2013$8,918,000
+23.2%
385,391
+43.1%
0.11%
+17.8%
Q2 2013$7,237,000
+63.7%
269,408
+54.8%
0.09%
-76.9%
Q1 2013$4,421,000
-3.5%
174,000
+3.5%
0.39%
-17.0%
Q4 2012$4,581,000
+33.1%
168,122
+31.6%
0.47%
+25.3%
Q3 2012$3,442,000
-41.8%
127,745
-48.8%
0.38%
+15.7%
Q1 2012$5,918,000
+785.9%
249,555
+682.1%
0.32%
+252.2%
Q4 2011$668,000
+15.4%
31,909
+3.2%
0.09%
-3.2%
Q3 2011$579,000
-17.4%
30,9090.0%0.10%
-4.0%
Q2 2011$701,000
+537.3%
30,909
+541.3%
0.10%
+421.1%
Q4 2010$110,000
+39.2%
4,8200.0%0.02%
+26.7%
Q3 2010$79,000
-33.6%
4,820
-39.9%
0.02%
-40.0%
Q2 2010$119,000
-60.6%
8,020
+20.6%
0.02%
-70.9%
Q1 2009$302,000
+1.3%
6,648
+47.4%
0.09%
+13.2%
Q4 2008$298,000
-24.9%
4,511
-26.3%
0.08%
-1.3%
Q3 2008$397,000
+42.8%
6,1230.0%0.08%
+57.1%
Q2 2008$278,000
+35.6%
6,123
+20.1%
0.05%
+58.1%
Q1 2008$205,0005,0980.03%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders